A significant advance in cancer investigation is occurring with the use of nanobodies to re-engage mutated p53. This vital malignant protector protein is frequently disabled in many types of tumors, leading https://bookmarkgenius.com/story21803437/mini-antibodies-reactivate-the-p53-protein-new-promising-pathway-for-malignant-management